Free consultation for new patients HSA / FSA accepted Licensed in 18 states + DC & PR*
The Lab

Semaglutide for Weight Loss: What Clinical Trials Show

Reviewed by Kenechukwu Okeke, MD

A laboratory pipette dispensing liquid into a test well plate

Semaglutide for Weight Loss: What the Clinical Trials Really Show THE LAB — TRIM FITT CLINICAL RESEARCH Semaglutide for Weight Loss: What the Clinical Trials Really Show Reviewed by the TRIM FITT Clinical Team · Evidence-Based Medicine Semaglutide has transformed the clinical approach to medically supervised weight optimization.

Originally researched for glycemic control in metabolic medicine, the semaglutide molecule has demonstrated significant clinical efficacy for sustained metabolic health in modern endocrinology. But what does the published clinical evidence show, and how do clinicians evaluate eligibility? What the Research Shows The STEP clinical trial program, published in the New England Journal of Medicine , is the most comprehensive body of evidence on semaglutide for weight management.

STEP 1 showed that adults with obesity who received 2.4 mg semaglutide weekly lost an average of 14.9% of body weight over 68 weeks — compared to 2.4% in the placebo group. STEP 4 demonstrated that patients who discontinued semaglutide regained two-thirds of their lost weight within a year, highlighting the importance of sustained treatment.

Semaglutide works by mimicking GLP-1, a hormone that reduces appetite, slows gastric emptying, and improves insulin sensitivity. Bottom line: Semaglutide is clinically proven to produce 10-15% average body weight reduction when combined with lifestyle modifications — a result that rivals many bariatric procedures without surgery.

What This Means at TRIM FITT At TRIM FITT, every protocol is built on peer-reviewed evidence. Our TRIM 40 program uses evidence-based GLP-1 therapy with ongoing clinical support, dose titration, and metabolic monitoring. Book a consultation to find out which protocol is right for you.

Schedule Your TRIM FITT Consultation → Compounded medications are prepared by state-licensed 503A compounding pharmacies pursuant to a valid prescription from a licensed healthcare provider for an individual patient. Compounded drugs are not reviewed or approved by the FDA. 📚 Peer-Reviewed Sources Wilding JPH et al.

— STEP 1 Trial, NEJM Rubino DM et al. — STEP 4 Trial, JAMA Educational purposes only. Not medical advice.

Consult with a TRIM FITT provider before starting any treatment. Ready to Start Your Protocol? TRIM FITT is a physician-led telehealth practice offering GLP-1 weight loss programs, ketamine therapy, and more — delivered to your door.

This article is for education and is not medical advice. Compounded medications are prepared by licensed 503A pharmacies and are not FDA approved for safety, effectiveness or quality.

Have a question this did not answer?

A clinician can look at your history rather than the general case.

Where do I start?

Three questions, then the right area of care.

Question 1 of 3

What has been feeling different?